Literature DB >> 9573551

Simultaneous determination of oxalate, citrate and sulfate in children's plasma with ion chromatography.

B Hoppe1, M J Kemper, M G Hvizd, D E Sailer, C B Langman.   

Abstract

To improve our understanding of both diagnosis and treatment of diseases of oxalate metabolism, we first set out to establish a new ion-chromatographic method to determine normal plasma levels of oxalate, citrate and sulfate from single plasma samples. In 50 infants and children (23 girls, 27 boys, aged 0.2 to 17 years) with normal renal function, blood was drawn in Li-heparin tubes, placed on ice and preserved immediately with 40 microliters M HCl/ml plasma in two ultracentrifugation steps. For measurement, plasma was injected onto an ion chromatography system with NaOH as the mobile phase, and then run as a linear gradient from 5 mM to 52.5 mM over 21 minutes. Analysis yielded measurable and reproducible oxalate (6.43 +/- 1.06 microM/liter), citrate (79.3 +/- 27.4 microM/liter) and sulfate (235.0 +/- 85.3 microM/liter) levels, without any age and gender specific differences. The least detectable plasma oxalate level was < 0.3 microM with a high reliability and reproducibility (coefficient of variance 1.95 to 4.75%). In conclusion, we established a reproducible, precise method to determine the relevant plasma anions involved in mineral metabolism, which heretofore have not been easily measurable. Studies of diseases of oxalate and citrate metabolism are ongoing on the basis of the normal plasma values achieved in this study.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573551     DOI: 10.1046/j.1523-1755.1998.00891.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

1.  The oxalate level in ultrafiltrate fluid collected from a dialyzer is useful for estimating the plasma oxalate level in hemodialysis patients.

Authors:  Makoto Ogi; Ryoetsu Abe; Tomohito Nishitani; Masanori Wakabayashi; Tsunemichi Wakabayashi
Journal:  Clin Exp Nephrol       Date:  2006-06       Impact factor: 2.801

2.  Individual variability in human blood metabolites identifies age-related differences.

Authors:  Romanas Chaleckis; Itsuo Murakami; Junko Takada; Hiroshi Kondoh; Mitsuhiro Yanagida
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

3.  Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice.

Authors:  Heike Hoyer-Kuhn; Sina Kohbrok; Ruth Volland; Jeremy Franklin; Barbara Hero; Bodo B Beck; Bernd Hoppe
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-02       Impact factor: 8.237

4.  Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation.

Authors:  Ludwig Stapenhorst; Robert Sassen; Bodo Beck; Norbert Laube; Albrecht Hesse; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2005-03-22       Impact factor: 3.714

5.  Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies.

Authors:  Bodo B Beck; Anne Baasner; Anja Buescher; Sandra Habbig; Nadine Reintjes; Markus J Kemper; Przemyslaw Sikora; Christoph Mache; Martin Pohl; Mirjam Stahl; Burkhard Toenshoff; Lars Pape; Henry Fehrenbach; Dorrit E Jacob; Bernd Grohe; Matthias T Wolf; Gudrun Nürnberg; Gökhan Yigit; Eduardo C Salido; Bernd Hoppe
Journal:  Eur J Hum Genet       Date:  2012-07-11       Impact factor: 4.246

Review 6.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

7.  Plasma oxalate level in pediatric calcium stone formers with or without secondary hyperoxaluria.

Authors:  Przemysław Sikora; Bodo Beck; Małgorzata Zajaczkowska; Bernd Hoppe
Journal:  Urol Res       Date:  2009-01-30

8.  Reference values of plasma oxalate in children and adolescents.

Authors:  Tadeusz Porowski; Walentyna Zoch-Zwierz; Jerzy Konstantynowicz; Agata Korzeniecka-Kozerska; Joanna Michaluk-Skutnik; Halina Porowska
Journal:  Pediatr Nephrol       Date:  2008-06-26       Impact factor: 3.714

9.  Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function-data from three placebo-controlled studies.

Authors:  Dawn S Milliner; Pierre Cochat; Sally-Anne Hulton; Jerome Harambat; Ana Banos; Bastian Dehmel; Elisabeth Lindner
Journal:  Pediatr Nephrol       Date:  2021-01-30       Impact factor: 3.714

10.  Vitamin C deficiency and impact of vitamin C administration among pediatric patients with advanced chronic kidney disease.

Authors:  Nattaphorn Hongsawong; Notethasoung Chawprang; Kulnipa Kittisakmontri; Parach Vittayananan; Konggrapun Srisuwan; Wattana Chartapisak
Journal:  Pediatr Nephrol       Date:  2020-07-19       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.